Dear %%first_name%%,
My economic/market telescope is still telling me that nearly all the crucial stars are just about in the right line, despite having to deal with that old ‘sell in May and run away’ curse for stocks – and a few Trump-related matters. In my article today, I tackle this question: are the signs aligning to help keep this stock market rally going?
Also in the Report today, in his fourth review for 2019, Paul Rickard looks at how our income and growth portfolios performed in April. A strong start to 2019 has seen both our portfolios return around 13%, with the income portfolio somewhat surprisingly doing better than the growth portfolio.
Achieving a $1 billion market cap on the ASX is a big deal. Cracking this amount usually gets the attention of more brokers and analysts, making a stock a serious player when it achieves a 10-digit market capitalisation. In his article today, James Dunn uncovers 5 candidates for the $1 billion capitalisation mark in the near future.
Following the April holiday-drought, last week there were12 upgrades in ratings for individual, listed ASX-stocks, vastly outnumbered by 22 downgrades. You can read more about this in Buy, Sell, Hold, – What the Brokers Say.
And finally, CMC Markets’ chief market strategist, Michael McCarthy explains why he likes Galaxy (GXY) and doesn’t like Resmed (RMD).
This is your VERY last chance to claim complimentary tickets to the Switzer Investor Strategy Day in Melbourne and Brisbane next week. Click on the event you would like to attend below:
Enjoy the read and your week!
Sincerely,
Peter Switzer